Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Melanoma × Genome × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Nevus 1 Melanoma 1 Dysplastic Nevus Syndrome 1

Interventions

pembrolizumab 50 Nivolumab 49 Ipilimumab 27 Cyclophosphamide 15 Specimen Handling 10 Radiosurgery 10 Magnetic Resonance Spectroscopy 10 fludarabine 9 Opdualag 9 Biopsy 8 relatlimab 7 binimetinib 7 aldesleukin 7 Interleukin-2 7 Blood Specimen Collection 7 encorafenib 5 cemiplimab 5 Paclitaxel 5 Immunotherapy 5 Bevacizumab 5 toripalimab 4 atezolizumab 4 Temozolomide 4 CTLA-4 Antigen 4 trametinib 3 spartalizumab 3 lifileucel 3 fludarabine phosphate 3 dabrafenib 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05446155 2024-01-23

BioMEL

Region Skane

Dysplastic Nevus Syndrome, Melanoma, Nevus, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡